Related Experiment Video
Updated: Jun 5, 2026

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
Published on: April 28, 2020
Pathophysiology and Treatment of Hepatic Encephalopathy
Sarah F Colmer1, Kathryn J Timko2, Amanda N Samuels3
1Department of Clinical Studies - New Bolton Center, University of Pennsylvania School of Veterinary Medicine, 382 West Street Road, Kennett Square, PA 19086, USA.
None:
Hepatic encephalopathy is a neurologic syndrome caused by hepatic insufficiency or portosystemic shunting, leading to the accumulation of ammonia and other neurotoxins. Clinical signs range from subtle behavioral changes to seizures and recumbency. Diagnosis relies on neurologic signs together with laboratory evidence of liver dysfunction, imaging, and sometimes biopsy. Importantly, hyperammonemia may occur without underlying hepatic dysfunction. Treatment focuses on addressing the underlying hepatic disease, reducing ammonia production and absorption, managing inflammation and cerebral edema, and providing supportive care. Prognosis varies widely and depends primarily on the underlying etiology, severity of hepatic damage, and response to therapy.
Related Concept Videos
Hepatic Encephalopathy
Encephalitis ll: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Encephalitis l: Introduction
